Abstract

Cholesterol is a key lipid in the stratum corneum, where it is critical for permeability barrier homeostasis. The epidermis is an active site of cholesterol synthesis, but inhibition of epidermal cholesterol synthesis with topically applied statins only modestly affects epidermal permeability barrier function, suggesting a possible compensatory role for extraepidermal cholesterol. Scavenger receptor class B type I (SR-BI) is a recently described cell surface receptor for high density lipoproteins (HDL) that mediates the selective uptake of cholesterol esters from circulating HDL. In the present study, we demonstrate that SR-BI is present in cultured human keratinocytes and that calcium-induced differentiation markedly decreases SR-BI levels. Additionally, the cell association of [(3)H]cholesterol-labeled HDL decreased in differentiated versus undifferentiated keratinocytes. Furthermore, the inhibition of cholesterol synthesis with simvastatin resulted in a 3-4-fold increase in both SR-BI mRNA and protein levels, whereas conversely, addition of 25-hydroxycholesterol suppressed SR-BI levels by approximately 50%. SR-BI mRNA is also expressed in murine epidermis, increasing by 50% in parallel with cholesterol requirements following acute barrier disruption. Because the increase is completely blocked by occlusion with a vapor-impermeable membrane, changes in epidermal SR-BI expression are regulated specifically by barrier requirements. Lastly, using immunofluorescence we demonstrated that SR-BI is present in human epidermis predominantly in the basal layer and increases following barrier disruption. In summary, the present study demonstrates first that SR-BI is expressed in keratinocytes and regulated by cellular cholesterol requirements, suggesting that it plays a role in keratinocyte cholesterol homeostasis. Second, the increase in SR-BI following barrier disruption suggests that SR-BI expression increases to facilitate cholesterol uptake leading to barrier restoration.

Highlights

  • From the ‡Dermatology and ʈMedical (Metabolism) Services, Department of Veterans Affairs Medical Center, San Francisco, California 94121, the Departments of §Dermatology and **Medicine, University of California, San Francisco School of Medicine, San Francisco, California 94143, and ¶R & D Department of Dermatological Science, POLA Laboratories, POLA Chemical Industries Inc., 560 Kashio-cho, Totsuka-ku, Yokohama 244-0812 Japan

  • We demonstrate that: (a) Scavenger receptor class B type I (SR-BI) is present in cultured human keratinocytes and in both murine and human epidermis, where it localizes mostly to the basal layer, (b) SR-BI expression decreases with keratinocyte differentiation and cholesterol excess but increases with sterol depletion, and (c) barrier disruption up-regulates SR-BI expression in a manner that is blocked by artificial barrier restoration

  • These results demonstrate first that SR-BI is present in human keratinocytes and second that keratinocyte SR-BI expression decreases in response to calcium-induced differentiation

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 277, No 4, Issue of January 25, pp. 2916 –2922, 2002 Printed in U.S.A. Scavenger Receptor Class B Type I Is Expressed in Cultured Keratinocytes and Epidermis. We demonstrate that: (a) SR-BI is present in cultured human keratinocytes and in both murine and human epidermis, where it localizes mostly to the basal layer, (b) SR-BI expression decreases with keratinocyte differentiation and cholesterol excess but increases with sterol depletion, and (c) barrier disruption up-regulates SR-BI expression in a manner that is blocked by artificial barrier restoration. Together, these results suggest that SR-BI may be important for the restoration of extracellular cholesterol needed to maintain permeability barrier homeostasis

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call